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Abstract
Introduction: In view of the conflicting evidence 
of helper T cell type 1 (Th1) or type 2 (Th2) pattern 
of cytokine synthesis in steroid sensitive nephrotic 
syndrome (SSNS), this study aimed  to assess type-1/
type-2 cytokines level in different stages of SSNS and to 
evaluate the role of IL-18. 
Methods: We prospectively studied thirty children with 
SSNS, aged 2–12 years. The children were evaluated 
in the active stage before treatment initiation and re-
evaluated again during remission while still on steroid 
treatment. A subgroup of children (21/30) was also 
evaluated during remission after steroid withdrawal. The 
control group included 30 healthy age- and sex-matched 
controls. Serum levels of IL-2, IFN-γ, ΙL-4, IL-13 and 
IL-18 were measured by ELISA.
Results: IL-2 levels were not significantly different 
between children in different stages of SSNS and 
controls (p > 0.05). Levels of IL-4, IL-13 and IL-18 
were significantly higher during the active stage of 
SSNS compared to remission and controls (p<0.05). 
Serum IFN-γ was significantly lower in children with 
active disease compared to remission stages and controls 
(p<0.05). In children with SSNS, serum levels of IL-18 
correlated significantly with both IL-4 and IL-13 during 
all stages (r = 0.72 and p<0.0001, r = 0.82 and p<0.0001, 
respectively).
Conclusion: Children with active SSNS seem to have a 
shift to type-2 cytokine production, and IL-18 expression 
is significantly correlated with this type-2 immune 
response.
Keywords: Nephrotic Syndrome; Type 1 cytokines; 
Type 2 cytokines
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Introduction
Idiopathic nephrotic syndrome (INS) is considered to be 
an immune-mediated disease [1]. How T-cells affect the 
course of the disease remains an unanswered question. 
However, circulating factors were proposed to be released 
from activated T-cells which may affect the pathogenesis 
of the disease. Several cytokines are considered prime 
candidates for the role of mediators of INS [2]. 
Based on the predominant cytokines, the immune response 
can be functionally subdivided into type-1 and type-2. 
Type-1 response normally prevails. It produces interferon-
gamma (IFN-γ) and interleukin (IL)-2 and enhances 
the production of complement-fixing and opsonizing 
antibodies as well as macrophage activation resulting in 
delayed type hypersensitivity (DTH) response. Type-2 
response is dominated by IL-4 and IL-13 and provides 
optimal help for antibody production. It promotes both 
mast cell growth and eosinophil differentiation and 
activation, resulting in humoral responses [3]. 
Measurement of cytokine level in serum or urine in INS 
patients has been performed by many investigators. 
Increased levels in serum or urine in relapse were 
reported for interleukin (IL)-2 [4], soluble IL-2 receptor 
[5-8], and (IFN-γ) [5, 9], IL-4 [9, 10], IL-12 [11]. INS has 
been suggested to be a Th2-dependent glomerular disease 
[12] depending on the evidenced association between it 
and atopy and allergy [13-15]. Many allergic disorders 
such as asthma, allergic rhinitis and eczema, are typically 
linked to the presence of a Th2 immunologic response. 
Further support to the hypothesis that INS is a Th2-
dependent glomerular disease comes from the elevated 
serum IgE and preservation of IgG4 observed in INS 
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[16-18]. In addition, levels of IL-4 and IL-13, which are 
two of the major Th2-associated cytokines, have been 
shown to be elevated in INS patients in relapse [9, 10, 
16, 19]. However, contradictory observations have been 
also reported [19- 21].
IL-18 is an exclusive cytokine which can stimulate 
both type-1 and type-2 immune responses depending 
on the cytokine environment [4]. Since Matsumoto and 
Kanmatsuse [22] have demonstrated that IL-18 was 
involved in the active stage of the disease and that there 
was a positive correlation between IL-18 production 
and disease activity, efforts have been made to identify 
the pathogenetic vascular permeability factors VPF(s) 
released from T-cells, such as cytokines, as well as to 
clarify the participating cells in its pathogenesis. For the 
last two decades many studies investigated the cytokine 
pattern in steroid sensitive nephrotic syndrome (SSNS) 
with sometimes conflicting results [5–7]. Besides, there is 
paucity of literature regarding the role of IL-18 in disease 
process. The current study aimed to evaluate type-1/
type-2 cytokine profile in children during different stages 
of primary SSNS and to investigate the involvement of 
IL-18.
Methods
This is a prospective longitudinal study carried out in 
Madinah Maternity and Children Hospital (MMCH), 
the main maternity and children referral hospital in 
Al-Madinah AI-Munawarah, KSA. The study investigated 
thirty children with proven first episode of steroid-
sensitive nephritic syndrome (SSNS) who were admitted 
in our department during the period from August 2010 
to August 2012. Active stage of SSNS was defined as 
increased urinary protein excretion (Albustix ≥2+ for 
at least three consecutive days or > 40 mg/m2/hour) 
and serum albumin ≤2.5 g/dL. Remission was defined 
as serum albumin concentration ≥ 3.5 g/dL and normal 
protein excretion (Albustix trace or negative for at least 
three consecutive days or ≤ 5 mg/m2/hour) [23]. Children 
with SSNS were evaluated during the active stage of the 
disease and during remission while still on steroids at a 
dose of 40 mg/m2 on alternate days. Twenty-one children 
were evaluated again during the remission phase after 
being off steroid treatment for at least 6 months. No patient 
was taking immunomodulating drug(s) nor did they have 
history of recent (within the previous 6 months) infection 
and/or inflammatory conditions, or abnormal urinary 
sediments (casts or crystalluria). The control group 
included thirty age- and sex-matched healthy children 
who had come to the outpatient Hematology Clinic in 
order to be tested for β-thalassemia trait and were found 
to be negative. They aged 2-12 years (15 males and 15 
females) and had urinary protein/ creatinine ratio less 
than 0.2 and serum albumin level of 4.1±4.6 mg/dL. 
The study was approved by the Ethics Committees 
of MMCH. The parents of all patients and controls 
were informed about the study and gave their written 
consent. Blood samples were collected from patients and 
controls in test tubes without anticoagulant under sterile 
conditions. Serum was separated by centrifugation at 
300g for 10 min, then divided in small aliquots and stored 
at −80oC for future serum cytokine assessment. Serum 
IFN-γ, IL-2, ΙL-4, IL-13 and IL-18 concentrations were 
measured by using quantitative colorimetric sandwich 
ELISA kits (R&D China Co. Ltd., Shanghai). Following 
the manufacturer’s instructions, each cytokine sample 
was run in duplicate and the mean cytokine concentration 
was calculated. 
Statistical analysis was performed using Statistical 
Package for Social Sciences version 17, (SPSS Inc., 
Chicago, IL, USA). Values were expressed as medians 
and ranges. The non-parametric Wilcoxon signed-rank 
test was used to compare differences between study 
groups with paired data. For non-paired data, statistical 
significance was analyzed by the Mann–Whitney U test. 
Spearman’s coefficient of correlation (r) and regression 
analysis model were used to determine the correlations. 
P value < 0.05 was considered to be statistically 
significant.
Results
The study investigated 30 children (17 males and 13 
females) in the active stage of SSNS, aged 2 to 12 years 
(median = 3.52 years). The control group consisted of 30 
healthy siblings of the patients (15 males and 15 females) 
aged 2 to 12 years (median = 4.12 years). There was no 
statistically significant difference between the group of 
children with nephrotic syndrome and the control group 
in regard to age or sex ((p > 0.05). Table-1 summarizes the 
results of serum IL-2, IFN-γ, IL-4, IL-13 and IL-18 levels 
and p values in all study groups. There was no significant 
difference in IL-2 levels between nephrotic children in 
all disease stages and controls (p > 0.05). Children in the 
active stage had significantly lower levels of IFN-γ when 
compared with the two remission phases (remission 
on steroids and remission off steroids (p = 0.005, 
p = 0.001, respectively) and the controls (p = 0.007), but 
there was no significant difference between controls and 
each of the two remission phases (p > 0.05). Children 
in the active stage of SSNS had significantly higher 
levels of IL-4 when compared with the two remission 
phases (p < 0.0001). Patients in both remission phases 
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showed significantly elevated IL-4 levels compared to 
controls (p < 0.0001 and p = 0.034, respectively). Serum 
IL-13 levels were significantly higher in the active 
stage of SSNS compared with the two remission phases 
(p < 0.0001). IL-13 levels were still elevated during 
both remission phases compared with the controls 
(p < 0.0001 and p = 0.002, respectively). In the active stage 
of SSNS, IL-18 levels were significantly higher compared 
with the two remission phases and controls (p = 0.003, 
p = 0.001, and p<0.0001, respectively). IL-18 levels in 
both remission phases, although lower than their levels 
in the active stage, remained significantly higher than 
controls (p<0.0001). 
As shown in Figure-1, linear regression analysis revealed 
that serum IL-18 and IL-4 levels were significantly 
correlated in nephrotic children in all disease stages 
(r = 0.72 and p<0.0001), including the active stage of the 
disease (r = 0.73 and p = 0.001). Figure-2 illustrates the 
significant correlation between serum IL-18 and IL-13 
levels in nephrotic children in all disease stages (r = 0.82 
and p < 0.0001) as well as in active stage of the disease 
(r = 0.76 and p = 0.001).
Discussion
Studies of the type-1/type-2 cytokine patterns in the sera 
of patients with SSNS have generally been variable and 
inconsistent. These conflicting results may be due to the 
differences in the immunologic techniques used to assess 
cytokine synthesis [24]. Our study has clearly shown 
that children with active SSNS showed down-regulation 
of type-1 immune response. IL-2 serum levels were not 
significantly different in children with SSNS in all stages. 
This is in agreement with pervious cited studies [16–19], 
including the study by Printza et al [24]. On the other 
hand, Zachwieja et al [16] demonstrated the presence of 
higher intracellular expression of IL-2 using a three-color 
flow cytometric assay. Considering the physiological fact 
that increased intracellular production does not usually 
result in increased secretion, we can partially explain the 
difference between our results and Zachwieja et al [25].
In the group of children with active disease, IFN-γ 
serum levels were lower than both remission groups as 
well as controls. Our results are in accordance with the 
results of two previous studies [24, 26] which showed a 
decreased production of IFN-γ by stimulated peripheral 
blood mononuclear cells in patients with active SSNS. 
Cheung et al [27] and Kaneko et al [28], who assessed 
the percentage of IFN-γ producing N cells in patients 
with SSNS, did not find significant difference between 
patients and controls. The predominance of type-2 
immune response in our children with active SSNS is 
further supported by the up-regulation of the serum 
levels of IL-4. These results are in agreement with earlier 
published works by Stokowski et al [20], Neuhaus et 
Tabl-1: Serum levels and median and range values of IL-2, IFN-γ, IL-4, IL-13 and IL-18 in patients during different stages of 
SSNS and in controls
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al [9], and Cho et al [10], who reported an increased 
synthesis of IL-4 by stimulated peripheral mononuclear 
cells in patients with active SSNS. Also the results of 
the current study are in agreement with Printza et al 
[24] Kang et al [29], and Lama et al [30]. On the other 
hand, Cheung et al [27] did not report any increase in the 
percentage of IL-4 producing T cells. 
Further support to the shift to type-2 immune response 
in our children with active SSNS is demonstrated by 
the increase of IL-13 serum levels in all our patients 
with SSNS. The results of this study are in accordance 
with pervious published studies [27, 19]. Yap et al [19] 
demonstrated an elevated expression of IL-13 mRNA 
using a semi-quantitative reverse transcriptase PCR 
technique. An experimental study on rat by Lai et al [31] 
demonstrated the occurrence of podocyte injury, inducing 
a minimal-change like nephropathy with the over-
expression of IL-13. Recently, Printza et al [24] reported 
that serum IL-13 levels were significantly higher in the 
active stage of SSNS compared with the two remission 
phases and that although IL-13 levels were even lower 
than in the active stage, they remained elevated during 
both remission phases compared with the controls.
Our results highlight an important finding of increased 
levels of IL-18 in all disease stages, and particularly in 
the active stage of SSNS compared with the controls. 
This elevation should be greatly emphasized considering 
that IL-18 is a unique cytokine that can trigger both 
type-1 and type-2 immune responses depending on the 
predominant cytokines [2]. Earlier in the literature IL-18 
was shown to be an IFN-γ trigger, which plays a critical 
role in the host defenses [32].  Recently, IL-18 has been 
postulated to induce IL-13 and/or IL-4 production by NK 
cells, mast cells and basophils [31, 32]. IL-18 is currently 
incriminated to play a potent role in various pathological 
conditions. The available data support its involvement 
in various diseases such as insulin dependent diabetes 
Figure-2: Correlation of serum IL-18 and IL-13 levels in children 
with steroid sensitive nephrotic syndrome (SSNS)  in all stages (a) 
and in children with active disease (b)
Figure-1: Correlation of serum IL-18 and IL-4 levels in children 
with steroid sensitive nephrotic syndrome (SSNS) in all stages (a) 
and in children with active disease (b)
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mellitus, rheumatoid arthritis, Chron’s disease and 
atopy. 
In collaboration with IL-12, IL-18 stimulates Th1-
mediated immune responses, which play a critical role 
in the host defense against infection with intracellular 
microbes through the induction of IFN-gamma. However, 
the overproduction of IL-12 and IL-18 induces severe 
inflammatory disorders, suggesting that IL-18 is a potent 
pro-inflammatory cytokine that has pathophysiological 
roles in several inflammatory conditions [2]. IL-18 
mRNA is expressed in a wide range of cells including 
Kupffer cells, macrophages, T cells, B cells, dendritic 
cells, osteoblasts, keratinocytes, astrocytes, and 
microglia. Thus, the pathophysiological role of IL-18 
has been extensively tested in the organs that contain 
these cells. Somewhat surprisingly, IL-18 alone can 
stimulate Th2 cytokine production as well as allergic 
inflammation. Therefore, the functions of IL-18 in vivo 
are very heterogeneous and complicated. In principle, 
IL-18 enhances the IL-12-driven Th1 immune responses, 
but it can also stimulate Th2 immune responses in the 
absence of IL-12 [31]. 
Printza et al [24] showed that in children with SSNS 
IL-18 levels were elevated in the active stage of the 
disease and that there was a positive correlation between 
IL-18 production and disease activity.  Our results also 
demonstrated that in SSNS, IL-18 was significantly 
correlated with IL-4 and IL-13 which are type-2 
cytokines.
Conclusion 
In conclusion, the current study reports that during the 
active stage of SSNS the balance is tipped in favor of 
type-2 cytokine pattern, and that apparently IL-18 is 
correlated with these type-2 cytokines. 
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